Home › Employers › Piedmont Henry Hospital, Inc.
Piedmont Henry Hospital, Inc.: H-1B salaries and sponsorship
Piedmont Henry Hospital, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $95,000.
Does Piedmont Henry Hospital, Inc. sponsor H-1B visas?
Piedmont Henry Hospital, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 15, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Medical Technologist Supervisor | 1 | $95,000 |
| Medical Technologist | 1 | $66,144 |
| Supervisor Laboratory | 1 | $99,750 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 1 | $95,000 |
| FY2025 | 1 | $66,144 |
| FY2026 | 1 | $99,750 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Supervisor Laboratory | $99,750 Level IV | Stockbridge, GA | Jun 15, 2026 | Nov 12, 2026 | Certified |
| Medical Technologist | $66,144 Level III | Stockbridge, GA | Apr 18, 2024 | May 6, 2024 | Certified, then withdrawn |
| Medical Technologist Supervisor | $95,000 Level IV | Stockbridge, GA | Nov 6, 2023 | Nov 13, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).